Korro Bio (NASDAQ:KRRO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Korro Bio (KRRO) operate in?

Korro Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Korro Bio Stock (NASDAQ: KRRO) stock price, news, charts, stock research, profile.

Open	$54.01
Close	-
Volume / Avg.	22.14K / 115.26K
Day Range	$54.01 - $57.94
52 Wk Range	30.01 - 98.00
Market Cap	$517.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	3.72%
Days to Cover	1

Recent News

United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

3 Stocks That Could Rise on European Bank Interest Rate Cuts

U.S. stocks reacted positively following the Federal Open Market Committee's announcement in mid-September that it would lower interest rates by 50 basis points, wider than many analysts had anticipated.

MarketBeat

Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications

NanoVation Therapeutics partners with Novo Nordisk to develop genetic medicines for cardiometabolic and rare diseases, utilizing NanoVation's lipid nanoparticle technology. The deal includes research funding and up to $600 million in potential milestone payments.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.6

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$54.01
Close	-
Volume / Avg.	22.14K / 115.26K
Day Range	$54.01 - $57.94
52 Wk Range	30.01 - 98.00
Market Cap	$517.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	3.72%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Korro Bio (KRRO) stock?

You can purchase shares of Korro Bio (NASDAQ:KRRO) through any online brokerage.

View our list of the best stock brokerages

Who are Korro Bio (KRRO) competitors?

Other companies in Korro Bio’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR), Pharming (NASDAQ:PHAR) and Sangamo Therapeutics (NASDAQ:SGMO).

What is the forecast, or price target, for Korro Bio (KRRO) stock?

Korro Bio has a consensus price target of $134.60.

What is the current price for Korro Bio (KRRO)?

The stock price for Korro Bio (NASDAQ: KRRO) is $55.67 last updated November 14, 2024 at 12:57 PM EST.

Does Korro Bio (KRRO) pay a dividend?

There are no upcoming dividends for Korro Bio.

When is Korro Bio (NASDAQ:KRRO) reporting earnings?

Korro Bio’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Korro Bio (KRRO) going to split?

There is no upcoming split for Korro Bio.

What sector and industry does Korro Bio (KRRO) operate in?

Korro Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Korro Bio

Korro Bio (KRRO) Forecast